Valuation
26% of the score
0median 56
An operating loss over the last year: there are no earnings to price.
LEGNLegend Biotech Corporation
$18.62-46% 1Y
$18.62
$16.6552 weeks$36.28
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 28 out of 100, Weak
Weak. Legend Biotech Corporation scores higher than 21% of the 1,794 companies Ryufin scores.
Carried by cycle position and earnings quality, held back by valuation and return on capital.
Healthcare median 29 · all companies 57
How the score has moved
At each fiscal year end, from the reports and price of the time22
22
28
28
202320242025today
The biggest move was up 6 points from 2024 to 2025, mostly the balance sheet.
Return on capital
18% of the score
0median 34
Over 6 years the business earned -36% a year after tax on the capital it uses.
2%
8%
15%
25%
-36%
None at 2% or less, full points from 25%full points
6 years agolatest -17%
Return on new capital
16% of the score
0median 49
No operating profit over the period, so nothing was earned to reinvest.
Capital allocation
14% of the score
40median 67
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countUp 9.3% a year over 5 years: new shares
05%
-3%
9.3%
0 pointsfull points
Assets against salesAssets grew 19% a year, sales 69%
10012%
-2%
-50%
0 pointsfull points
Cycle position
12% of the score
100median 62
Today's operating margin of -13% is -0.49x its normal 27%: near a trough. Normal is half the 8 year median, half the last four years, so a margin that has held is not taken for a peak.
2x
1.5x
1x
0.7x
-0.5x
A trough earns points, a peak costs themfull points
8 years agonow -13%
Balance sheet
8% of the score
50median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDAMore cash than debt
100Interest coverAn operating loss: the interest is not covered
01.5x
12x
-6.4x
0 pointsfull points
Earnings quality
6% of the score
100median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
AccrualsCash ran ahead of profit by 11.6% of assets
1008%
0%
-8%
-12%
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. Where a criterion cannot be measured from the filings it is taken out and the remaining weights scale up; a company needs 60% of the weight covered, and always a price, to get a score.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2025-12-31, latest annual report FY2025.
On our screens:Stocks with no debt